More tools:Markets·Screener·Research·Chat

Treace Medical Concepts, Inc. Common Stock (TMCI) Financial Statements

Treace Medical Concepts, Inc. Common Stock
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG00GQKR6N3
XNAS · usd
4.53▼ 0.10 (-2.16%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close4.63
Day's Range4.50 – 4.73
52-Week Range1.17 – 7.63
Volume112.3K
Avg Volume363.3K
Share Statistics
Shares Outstanding
Employees450
ExchangeXNAS
Listed2021-04-23
Share count as of July 31, 2026
Loading Income Statement…
Key questions about Treace Medical Concepts, Inc. Common Stock (TMCI)
What is Treace Medical Concepts, Inc. Common Stock's Market Cap?
Treace Medical Concepts, Inc. Common Stock's Market Cap is $294.6M, based on as-reported figures from SEC (XBRL) filings.
What is Treace Medical Concepts, Inc. Common Stock's Enterprise Value?
Treace Medical Concepts, Inc. Common Stock's Enterprise Value is $308.2M, based on as-reported figures from SEC (XBRL) filings.
What is Treace Medical Concepts, Inc. Common Stock's Price / Sales?
Treace Medical Concepts, Inc. Common Stock's Price / Sales is 1.4×, based on as-reported figures from SEC (XBRL) filings.
What is Treace Medical Concepts, Inc. Common Stock's EV / Revenue?
Treace Medical Concepts, Inc. Common Stock's EV / Revenue is 1.5×, based on as-reported figures from SEC (XBRL) filings.
What is Treace Medical Concepts, Inc. Common Stock's EV / EBITDA?
Treace Medical Concepts, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Treace Medical Concepts, Inc. Common Stock's Revenue (TTM)?
Treace Medical Concepts, Inc. Common Stock's Revenue (TTM) is $205.3M, based on as-reported figures from SEC (XBRL) filings.
What is Treace Medical Concepts, Inc. Common Stock's Net Income (TTM)?
Treace Medical Concepts, Inc. Common Stock's Net Income (TTM) is -$59.5M, based on as-reported figures from SEC (XBRL) filings.
What is Treace Medical Concepts, Inc. Common Stock's EBITDA?
Treace Medical Concepts, Inc. Common Stock's EBITDA is -$45.4M, based on as-reported figures from SEC (XBRL) filings.
What is Treace Medical Concepts, Inc. Common Stock's Diluted EPS (TTM)?
Treace Medical Concepts, Inc. Common Stock's Diluted EPS (TTM) is -0.92, based on as-reported figures from SEC (XBRL) filings.
What is Treace Medical Concepts, Inc. Common Stock's EBITDA Margin?
Treace Medical Concepts, Inc. Common Stock's EBITDA Margin is -22.1%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth-4.2%-10.2%-9.0%+11.4%
Cost of goods sold
Gross profit
% of revenue78.5%79.3%80.6%79.1%
Operating expenses
Sales and marketing
Research and development
General and administrative
Total operating expenses
% of revenue111.4%115.6%90.1%110.3%
Loss from operations
% of revenue-33.0%-36.4%-9.5%-31.2%
Interest income
Interest expense
Other income, net
Other non-operating income (expense), net
Net loss
% of revenue-35.0%-38.1%-15.0%-32.4%
Net loss per share, basic
Net loss per share, diluted